Many of the conferences, meetings, and workshops convened in anticipation of a pandemic have focused on the specific strategies that can be used in fighting such a pandemic. The contributors to this abstract take a different tack and consider the creation of ethical guidelines for governments, health-care systems, and clinicians to be used in planning […]
Tag Archives | Vaccines
The Advance Market Commitment (AMC) is a new approach to public health funding designed to stimulate the development and manufacture of affordable vaccines tailored to the needs of developing countries. The pilot AMC against pneumococcal disease was launched in June 2009 with a collective US$ 1.5 billion donor commitment.
DNDi aims to develop new drugs and treatments for neglected diseases (NDs) and to ensure equitable access to effective therapeutic options for patients in need in developing countries.
Malignant lesions of the uterine cervix constitute a major public health problem in the world, especially in the developping countries.Human papilloma virus (HPV) was first associated to cervical cancer more than twenty years ago.
With the recent breakthrough in Genomics and Proteomics and availability of quantum of information on Human, Mosquito and Parasite Genome and the application of advanced molecular and biotechnological techniques the research has entered in to a new arena with more prospects on vaccine development, drug delivery system, diagnostics, alternative methods of control and evaluation of […]
Plenary V addressed the current challenges and conditions for effective capacity building in the health workforce as well as medical research to improve health and give access to health care in developing countries.
Health research has several crucial roles to play in ensuring that people everywhere have access to health.
The IFPMA Clinical Trials Portal www.ifpma.org/clinicaltrials is the first internet search engine to link to online information about on-going and completed clinical trials sponsored by research-based pharmaceutical companies worldwide.
The symposium on “Research and Access to Health: Ethical Concerns” has highlighted the fact that strong laws are a powerful tool to protect participants in experimental clinical trials.
Over the past decade, Latin America has evolved into a very dynamic area for conducting Clinical Research, particularly with regard to the development of new antimicrobials and vaccines. Between 1995 and 2000, the number of clinical trials executed in the region rose over a factor of ten.